gatifloxacin has been researched along with Recrudescence in 11 studies
Gatifloxacin: A fluoroquinolone antibacterial agent and DNA TOPOISOMERASE II inhibitor that is used as an ophthalmic solution for the treatment of BACTERIAL CONJUNCTIVITIS.
gatifloxacin : A monocarboxylic acid that is 4-oxo-1,4-dihydroquinoline-3-carboxylic acid which is substituted on the nitrogen by a cyclopropyl group and at positions 6, 7, and 8 by fluoro, 3-methylpiperazin-1-yl, and methoxy groups, respectively. Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family, that like other members of that family, inhibits the bacterial topoisomerase type-II enzymes.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To compare gatifloxacin with amoxicillin/clavulanate in children with recurrent or nonresponsive acute otitis media (AOM)." | 9.11 | Randomized, investigator-blinded, multicenter study of gatifloxacin versus amoxicillin/clavulanate treatment of recurrent and nonresponsive otitis media in children. ( Arguedas, A; Echols, R; Hamed, KA; Pierce, P; Rodriguez, A; Sáez-Llorens, X; Yang, J, 2005) |
| "To compare the clinical efficacy of gatifloxacin with amoxicillin/clavulanate for the treatment of acute otitis media treatment failure and recurrent otitis media." | 9.11 | Randomized, investigator-blinded, multicenter, comparative study of gatifloxacin versus amoxicillin/clavulanate in recurrent otitis media and acute otitis media treatment failure in children. ( Arguedas, A; Biswas, D; Echols, R; Hamed, KA; Husseman, M; Pichichero, M; Pierce, P; Sher, L, 2005) |
| "To document the bacteriologic and clinical efficacy of gatifloxacin in recurrent/nonresponsive acute otitis media (AOM)." | 9.10 | Bacteriologic and clinical efficacy of oral gatifloxacin for the treatment of recurrent/nonresponsive acute otitis media: an open label, noncomparative, double tympanocentesis study. ( Dagan, R; Echols, RM; Greenberg, D; Hamed, KA; Jacobs, MR; Ledeine, JM; Leiberman, A; Leibovitz, E; Pierce, PF; Piglansky, L; Press, J; Raiz, S, 2003) |
| "This was an open label, multicenter trial in which patients with recurrent otitis media or acute otitis media (AOM) treatment failure were treated with 10 mg/kg gatifloxacin oral suspension once daily for 10 days." | 9.10 | Open label, multicenter study of gatifloxacin treatment of recurrent otitis media and acute otitis media treatment failure. ( Arguedas, A; Hamed, K; Lopez, E; Pierce, PF; Sáez-Llorens, X; Sher, L; Skuba, K, 2003) |
| " This study describes the safety and efficacy of gatifloxacin when used for treatment of children with recurrent acute otitis media (ROM) or acute otitis media (AOM) treatment failure (AOMTF)." | 8.82 | Safety and efficacy of gatifloxacin therapy for children with recurrent acute otitis media (AOM) and/or AOM treatment failure. ( Arguedas, A; Dagan, R; Echols, R; Hamed, K; Pichichero, ME; Saez-Llorens, X; Sher, L, 2005) |
| "The epidemiology of typhoid fever in South Asia has changed." | 5.48 | Effectiveness of treatment regimens for Typhoid fever in the nalidixic acid-resistant S. typhi (NARST) era in South India. ( Balaji, V; Bandyopadhyay, R; Jasmine, S; Rupali, P; Sathyendra, S; Yadav, B, 2018) |
| "To compare gatifloxacin with amoxicillin/clavulanate in children with recurrent or nonresponsive acute otitis media (AOM)." | 5.11 | Randomized, investigator-blinded, multicenter study of gatifloxacin versus amoxicillin/clavulanate treatment of recurrent and nonresponsive otitis media in children. ( Arguedas, A; Echols, R; Hamed, KA; Pierce, P; Rodriguez, A; Sáez-Llorens, X; Yang, J, 2005) |
| "To compare the clinical efficacy of gatifloxacin with amoxicillin/clavulanate for the treatment of acute otitis media treatment failure and recurrent otitis media." | 5.11 | Randomized, investigator-blinded, multicenter, comparative study of gatifloxacin versus amoxicillin/clavulanate in recurrent otitis media and acute otitis media treatment failure in children. ( Arguedas, A; Biswas, D; Echols, R; Hamed, KA; Husseman, M; Pichichero, M; Pierce, P; Sher, L, 2005) |
| "To document the bacteriologic and clinical efficacy of gatifloxacin in recurrent/nonresponsive acute otitis media (AOM)." | 5.10 | Bacteriologic and clinical efficacy of oral gatifloxacin for the treatment of recurrent/nonresponsive acute otitis media: an open label, noncomparative, double tympanocentesis study. ( Dagan, R; Echols, RM; Greenberg, D; Hamed, KA; Jacobs, MR; Ledeine, JM; Leiberman, A; Leibovitz, E; Pierce, PF; Piglansky, L; Press, J; Raiz, S, 2003) |
| "This was an open label, multicenter trial in which patients with recurrent otitis media or acute otitis media (AOM) treatment failure were treated with 10 mg/kg gatifloxacin oral suspension once daily for 10 days." | 5.10 | Open label, multicenter study of gatifloxacin treatment of recurrent otitis media and acute otitis media treatment failure. ( Arguedas, A; Hamed, K; Lopez, E; Pierce, PF; Sáez-Llorens, X; Sher, L; Skuba, K, 2003) |
| " This study describes the safety and efficacy of gatifloxacin when used for treatment of children with recurrent acute otitis media (ROM) or acute otitis media (AOM) treatment failure (AOMTF)." | 4.82 | Safety and efficacy of gatifloxacin therapy for children with recurrent acute otitis media (AOM) and/or AOM treatment failure. ( Arguedas, A; Dagan, R; Echols, R; Hamed, K; Pichichero, ME; Saez-Llorens, X; Sher, L, 2005) |
| "The differences in TB recurrence rates between the G and C arms was statistically significant (p = 0." | 2.78 | Randomized clinical trial of thrice-weekly 4-month moxifloxacin or gatifloxacin containing regimens in the treatment of new sputum positive pulmonary tuberculosis patients. ( Balasubramanian, R; Banurekha, VV; Baskaran, D; Chandrasekar, C; Charles, N; Ganapathy, S; Gangadevi, NP; Iliayas, AS; Jagannath, K; Jawahar, MS; Kumar, MM; Kumar, SR; Kumar, V; Mohan, V; Narayanan, PR; Paramasivan, CN; Parthasarathy, RT; Ponnuraja, C; Rahman, F; Ramachandran, R; Raman, B; Sakthivel, MR; Selvakumar, N; Shanmugam, G; Venkatesan, P, 2013) |
| "The epidemiology of typhoid fever in South Asia has changed." | 1.48 | Effectiveness of treatment regimens for Typhoid fever in the nalidixic acid-resistant S. typhi (NARST) era in South India. ( Balaji, V; Bandyopadhyay, R; Jasmine, S; Rupali, P; Sathyendra, S; Yadav, B, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (81.82) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bandyopadhyay, R | 1 |
| Balaji, V | 1 |
| Yadav, B | 1 |
| Jasmine, S | 1 |
| Sathyendra, S | 1 |
| Rupali, P | 1 |
| Jawahar, MS | 1 |
| Banurekha, VV | 1 |
| Paramasivan, CN | 1 |
| Rahman, F | 1 |
| Ramachandran, R | 1 |
| Venkatesan, P | 1 |
| Balasubramanian, R | 1 |
| Selvakumar, N | 1 |
| Ponnuraja, C | 1 |
| Iliayas, AS | 1 |
| Gangadevi, NP | 1 |
| Raman, B | 1 |
| Baskaran, D | 1 |
| Kumar, SR | 1 |
| Kumar, MM | 1 |
| Mohan, V | 1 |
| Ganapathy, S | 1 |
| Kumar, V | 1 |
| Shanmugam, G | 1 |
| Charles, N | 1 |
| Sakthivel, MR | 1 |
| Jagannath, K | 1 |
| Chandrasekar, C | 1 |
| Parthasarathy, RT | 1 |
| Narayanan, PR | 1 |
| Lekhanont, K | 1 |
| Chuckpaiwong, V | 1 |
| Chongtrakool, P | 1 |
| Aroonroch, R | 1 |
| Vongthongsri, A | 1 |
| Bello, S | 1 |
| Torres, A | 1 |
| Leibovitz, E | 1 |
| Piglansky, L | 1 |
| Raiz, S | 1 |
| Greenberg, D | 1 |
| Hamed, KA | 3 |
| Ledeine, JM | 1 |
| Press, J | 1 |
| Leiberman, A | 1 |
| Echols, RM | 1 |
| Pierce, PF | 2 |
| Jacobs, MR | 1 |
| Dagan, R | 2 |
| Arguedas, A | 4 |
| Sher, L | 3 |
| Lopez, E | 1 |
| Sáez-Llorens, X | 3 |
| Hamed, K | 2 |
| Skuba, K | 1 |
| Rodriguez, A | 1 |
| Yang, J | 1 |
| Pierce, P | 2 |
| Echols, R | 3 |
| Husseman, M | 1 |
| Pichichero, M | 1 |
| Biswas, D | 1 |
| Pichichero, ME | 1 |
| Clearfield, M | 1 |
| Richard, GA | 1 |
| Mathew, CP | 1 |
| Kirstein, JM | 1 |
| Orchard, D | 1 |
| Yang, JY | 1 |
1 review available for gatifloxacin and Recrudescence
| Article | Year |
|---|---|
Safety and efficacy of gatifloxacin therapy for children with recurrent acute otitis media (AOM) and/or AOM treatment failure.
Topics: Anti-Infective Agents; Child; Clinical Trials as Topic; Fluoroquinolones; Gatifloxacin; Humans; Otit | 2005 |
6 trials available for gatifloxacin and Recrudescence
4 other studies available for gatifloxacin and Recrudescence
| Article | Year |
|---|---|
Effectiveness of treatment regimens for Typhoid fever in the nalidixic acid-resistant S. typhi (NARST) era in South India.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ciprofloxacin; Cohort Studies; Dr | 2018 |
Pythium insidiosum keratitis in contact lens wear: a case report.
Topics: Anti-Infective Agents; Contact Lenses, Hydrophilic; Corneal Ulcer; Disposable Equipment; Drug Admini | 2009 |
[Pneumococcus and quinolone resistance].
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Child, Preschool; Ciproflo | 2003 |
C-reactive protein levels and outcomes after statin therapy.
Topics: Anticholesteremic Agents; Atorvastatin; Biomarkers; C-Reactive Protein; Cholesterol, LDL; Coronary D | 2006 |